Letters |

Necrosectomy for Infected Necrotizing Pancreatitis

Peter J. Fagenholz, MD; Carlos Fernández-del Castillo, MD
JAMA. 2012;307(24):2584-2585. doi:10.1001/jama.2012.5970.
Text Size: A A A
Published online


To the Editor: The findings of the PENGUIN (Pancreatitis, Endoscopic Transgastric vs Primary Necrosectomy in Patients With Infected Necrosis) trial1 suggest that endoscopic transgastric necrosectomy reduces death or complications compared with surgical necrosectomy for the treatment of infected necrotizing pancreatitis. These results are heavily influenced by an unusually high 40% mortality rate in the surgical necrosectomy group, which we believe calls into question the reported superiority of endoscopic transgastric necrosectomy. The latest published data from our institution show an 11% mortality rate after open surgical necrosectomy in 167 patients.2 Other contemporary surgical series have demonstrated a mortality of 4% to 18%.3 Based on these data, the advantages of endoscopic necrosectomy are less clear. Future studies will continue to define the role of endoscopic necrosectomy in patients with infected necrotizing pancreatitis, but unless surgical therapy is performed with acceptable mortality, the effect will be questionable. At centers achieving comparable results with other techniques, the limitations of endoscopic transgastric debridement—the need for multiple procedures, the requirement for favorable anatomy, and the difficulty of acquiring adequate expertise—may supersede small advantages in morbidity and mortality.


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview




June 27, 2012
Olaf J. Bakker, MD; Hjalmar C. van Santvoort, MD, PhD; Marc G. Besselink, MD, PhD
JAMA. 2012;307(24):2584-2585. doi:10.1001/jama.2012.5974.
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...